| Dr Liam J Hurley, MD | |
|
231 Sutton St, Ste 1d, North Andover, MA 01845-1620 | |
| (978) 686-3877 | |
| (978) 686-9586 |
| Full Name | Dr Liam J Hurley |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 38 Years |
| Location | 231 Sutton St, North Andover, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093765992 | NPI | - | NPPES |
| 9719911 | Medicaid | MA | |
| 3109470 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 57975 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Heywood Hospital - | Gardner, MA | Hospital |
| Holy Family Hospital | Methuen, MA | Hospital |
| Athol Memorial Hospital | Athol, MA | Hospital |
| Lawrence General Hospital | Lawrence, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steward Medical Group Inc | 2860688728 | 1404 |
| Heywood Medical Group Inc. | 6901882836 | 82 |
| Steward Medical Group Inc | 2860688728 | 1404 |
News Archive
Consumers for Dental Choice, the advocacy wing of the mercury-free dentistry movement, commends the U.S. Environmental Protection Agency's proposed rule to require dental clinics to install and maintain amalgam separators.
A compound found in green tea could be a weapon in treatments for tackling cancer, according to newly-published research at the University of Strathclyde in Glasgow, Scotland.
Results from two clinical trials show that patients with early-stage breast cancer who received trastuzumab (Herceptin) in combination with chemotherapy had a 52 percent decrease in risk for breast cancer recurrence, compared with patients who received the same chemotherapy without the drug. The difference is statistically highly significant.
MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning medication. Physicians at MedStar Heart at MedStar Washington Hospital Center were the first in the Washington metropolitan region to successfully implant the WATCHMAN Device on June 16 in two patients with atrial fibrillation (A-fib).
Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus. Renal cell carcinoma is the most common form of kidney cancer in adults and currently there is no effective treatment for the disease once it has spread outside of the kidney.
› Verified 3 days ago
| Entity Name | Henry Heywood Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205823879 PECOS PAC ID: 1658262605 Enrollment ID: O20040322000360 |
News Archive
Consumers for Dental Choice, the advocacy wing of the mercury-free dentistry movement, commends the U.S. Environmental Protection Agency's proposed rule to require dental clinics to install and maintain amalgam separators.
A compound found in green tea could be a weapon in treatments for tackling cancer, according to newly-published research at the University of Strathclyde in Glasgow, Scotland.
Results from two clinical trials show that patients with early-stage breast cancer who received trastuzumab (Herceptin) in combination with chemotherapy had a 52 percent decrease in risk for breast cancer recurrence, compared with patients who received the same chemotherapy without the drug. The difference is statistically highly significant.
MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning medication. Physicians at MedStar Heart at MedStar Washington Hospital Center were the first in the Washington metropolitan region to successfully implant the WATCHMAN Device on June 16 in two patients with atrial fibrillation (A-fib).
Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus. Renal cell carcinoma is the most common form of kidney cancer in adults and currently there is no effective treatment for the disease once it has spread outside of the kidney.
› Verified 3 days ago
| Entity Name | Heywood Medical Group Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699762286 PECOS PAC ID: 6901882836 Enrollment ID: O20040629001351 |
News Archive
Consumers for Dental Choice, the advocacy wing of the mercury-free dentistry movement, commends the U.S. Environmental Protection Agency's proposed rule to require dental clinics to install and maintain amalgam separators.
A compound found in green tea could be a weapon in treatments for tackling cancer, according to newly-published research at the University of Strathclyde in Glasgow, Scotland.
Results from two clinical trials show that patients with early-stage breast cancer who received trastuzumab (Herceptin) in combination with chemotherapy had a 52 percent decrease in risk for breast cancer recurrence, compared with patients who received the same chemotherapy without the drug. The difference is statistically highly significant.
MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning medication. Physicians at MedStar Heart at MedStar Washington Hospital Center were the first in the Washington metropolitan region to successfully implant the WATCHMAN Device on June 16 in two patients with atrial fibrillation (A-fib).
Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus. Renal cell carcinoma is the most common form of kidney cancer in adults and currently there is no effective treatment for the disease once it has spread outside of the kidney.
› Verified 3 days ago
| Entity Name | Athol Memorial Hospital Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336120047 PECOS PAC ID: 7911959846 Enrollment ID: O20050218000228 |
News Archive
Consumers for Dental Choice, the advocacy wing of the mercury-free dentistry movement, commends the U.S. Environmental Protection Agency's proposed rule to require dental clinics to install and maintain amalgam separators.
A compound found in green tea could be a weapon in treatments for tackling cancer, according to newly-published research at the University of Strathclyde in Glasgow, Scotland.
Results from two clinical trials show that patients with early-stage breast cancer who received trastuzumab (Herceptin) in combination with chemotherapy had a 52 percent decrease in risk for breast cancer recurrence, compared with patients who received the same chemotherapy without the drug. The difference is statistically highly significant.
MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning medication. Physicians at MedStar Heart at MedStar Washington Hospital Center were the first in the Washington metropolitan region to successfully implant the WATCHMAN Device on June 16 in two patients with atrial fibrillation (A-fib).
Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus. Renal cell carcinoma is the most common form of kidney cancer in adults and currently there is no effective treatment for the disease once it has spread outside of the kidney.
› Verified 3 days ago
| Entity Name | Northeast Urologic Surgery, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053361352 PECOS PAC ID: 9638154016 Enrollment ID: O20080228000145 |
News Archive
Consumers for Dental Choice, the advocacy wing of the mercury-free dentistry movement, commends the U.S. Environmental Protection Agency's proposed rule to require dental clinics to install and maintain amalgam separators.
A compound found in green tea could be a weapon in treatments for tackling cancer, according to newly-published research at the University of Strathclyde in Glasgow, Scotland.
Results from two clinical trials show that patients with early-stage breast cancer who received trastuzumab (Herceptin) in combination with chemotherapy had a 52 percent decrease in risk for breast cancer recurrence, compared with patients who received the same chemotherapy without the drug. The difference is statistically highly significant.
MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning medication. Physicians at MedStar Heart at MedStar Washington Hospital Center were the first in the Washington metropolitan region to successfully implant the WATCHMAN Device on June 16 in two patients with atrial fibrillation (A-fib).
Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus. Renal cell carcinoma is the most common form of kidney cancer in adults and currently there is no effective treatment for the disease once it has spread outside of the kidney.
› Verified 3 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000332 |
News Archive
Consumers for Dental Choice, the advocacy wing of the mercury-free dentistry movement, commends the U.S. Environmental Protection Agency's proposed rule to require dental clinics to install and maintain amalgam separators.
A compound found in green tea could be a weapon in treatments for tackling cancer, according to newly-published research at the University of Strathclyde in Glasgow, Scotland.
Results from two clinical trials show that patients with early-stage breast cancer who received trastuzumab (Herceptin) in combination with chemotherapy had a 52 percent decrease in risk for breast cancer recurrence, compared with patients who received the same chemotherapy without the drug. The difference is statistically highly significant.
MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning medication. Physicians at MedStar Heart at MedStar Washington Hospital Center were the first in the Washington metropolitan region to successfully implant the WATCHMAN Device on June 16 in two patients with atrial fibrillation (A-fib).
Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus. Renal cell carcinoma is the most common form of kidney cancer in adults and currently there is no effective treatment for the disease once it has spread outside of the kidney.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Liam J Hurley, MD 231 Sutton St, Ste 1d, North Andover, MA 01845-1620 Ph: (978) 686-3877 | Dr Liam J Hurley, MD 231 Sutton St, Ste 1d, North Andover, MA 01845-1620 Ph: (978) 686-3877 |
News Archive
Consumers for Dental Choice, the advocacy wing of the mercury-free dentistry movement, commends the U.S. Environmental Protection Agency's proposed rule to require dental clinics to install and maintain amalgam separators.
A compound found in green tea could be a weapon in treatments for tackling cancer, according to newly-published research at the University of Strathclyde in Glasgow, Scotland.
Results from two clinical trials show that patients with early-stage breast cancer who received trastuzumab (Herceptin) in combination with chemotherapy had a 52 percent decrease in risk for breast cancer recurrence, compared with patients who received the same chemotherapy without the drug. The difference is statistically highly significant.
MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning medication. Physicians at MedStar Heart at MedStar Washington Hospital Center were the first in the Washington metropolitan region to successfully implant the WATCHMAN Device on June 16 in two patients with atrial fibrillation (A-fib).
Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus. Renal cell carcinoma is the most common form of kidney cancer in adults and currently there is no effective treatment for the disease once it has spread outside of the kidney.
› Verified 3 days ago
Dr. Steven Robert Previte, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 231 Sutton St, Unit 1d, North Andover, MA 01845 Phone: 978-686-3877 Fax: 978-686-9586 | |
Dr. George E Canellakis, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 231 Sutton St, Unit 1d, North Andover, MA 01845 Phone: 978-686-3877 Fax: 978-686-9586 | |
Dr. Ossama El Sayed Sakr, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 231 Sutton St, Unit 1d, North Andover, MA 01845 Phone: 978-686-3877 Fax: 978-686-9586 | |
Dr. Charles Robert Burke, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 231 Sutton St, Unit 1d, North Andover, MA 01845 Phone: 978-686-3877 Fax: 978-686-9586 | |
Teodora Kurteva, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 231 Sutton St Ste 1d, North Andover, MA 01845 Phone: 978-686-3877 Fax: 978-686-9586 | |
Dr. Christopher Peter Ip, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 231 Sutton St, Suite 1 D, North Andover, MA 01845 Phone: 978-686-3877 Fax: 978-686-9586 |